ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,303.27
0.12%
Dow Jones
40,003.59
0.34%
US Dollar vs MXN
16.6086
0.00%
Brent Oil
83.76
0.00%
Bitcoin
67,254.71
0.47%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. Belite Bio Inc (BLTE)

  7. Belite Bio Inc (BLTE) Noticias

BLTE

Belite Bio (BLTE)

Belite Bio Inc
Fecha:
Ordernar por:
 Showing the most relevant articles for your search:NASDAQ:BLTE
FechaHoraFuenteTítuloSímboloCompañía
17/05/202410:36Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:BLTEBelite Bio Inc
14/05/202407:00GlobeNewswire Inc.Belite Bio to Participate in the Benchmark’s 4th Annual Healthcare House Call Investor ConferenceNASDAQ:BLTEBelite Bio Inc
13/05/202420:57Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:BLTEBelite Bio Inc
13/05/202420:50GlobeNewswire Inc.Belite Bio Reports First-Quarter 2024 Financial Results and Provides Corporate UpdateNASDAQ:BLTEBelite Bio Inc
13/05/202407:00GlobeNewswire Inc.Belite Bio to Participate in the H.C. Wainwright 2nd Annual BioConnect Investor ConferenceNASDAQ:BLTEBelite Bio Inc
08/05/202407:00GlobeNewswire Inc.Belite Bio to Host Webcast on May 14, 2024, to Discuss First Quarter 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
06/05/202407:15GlobeNewswire Inc.Belite Bio to Participate in Key Opinion Leader Webinar to Discuss Unmet Needs In Stargardt Disease (STGD1) and Geographic Atrophy (GA) and Perspectives On TinlarebantNASDAQ:BLTEBelite Bio Inc
06/05/202407:00GlobeNewswire Inc.Belite Bio Presents Additional Analysis from Phase 2 Study of Tinlarebant in Stargardt Disease at the ARVO Annual MeetingNASDAQ:BLTEBelite Bio Inc
01/05/202415:15GlobeNewswire Inc.Belite Bio Announces Presentation at the Association for Research in Vision and Ophthalmology 2024 Annual MeetingNASDAQ:BLTEBelite Bio Inc
25/04/202418:15GlobeNewswire Inc.Belite Bio Announces $25 Million Registered Direct OfferingNASDAQ:BLTEBelite Bio Inc
22/03/202407:00GlobeNewswire Inc.Belite Bio Announces PMDA Submission of Tinlarebant for Stargardt Disease Clinical Trial in JapanNASDAQ:BLTEBelite Bio Inc
11/03/202421:28GlobeNewswire Inc.Belite Bio Announces Availability of Annual Report on Form 20-F Through Company WebsiteNASDAQ:BLTEBelite Bio Inc
11/03/202420:27GlobeNewswire Inc.Belite Bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate UpdateNASDAQ:BLTEBelite Bio Inc
06/03/202407:00GlobeNewswire Inc.Belite Bio to Host Webcast on March 12, 2024, to Discuss Fourth Quarter and Full Year 2024 Financial ResultsNASDAQ:BLTEBelite Bio Inc
04/03/202407:00GlobeNewswire Inc.Belite Bio to Participate in the Leerink Partners Global Biopharma ConferenceNASDAQ:BLTEBelite Bio Inc
12/02/202420:08Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:BLTEBelite Bio Inc
07/02/202407:00GlobeNewswire Inc.Belite Bio to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:BLTEBelite Bio Inc
30/11/202307:00GlobeNewswire Inc.Belite Bio to Participate in the Benchmark Company’s Upcoming Discovery One-on-One Investor ConferenceNASDAQ:BLTEBelite Bio Inc
20/11/202307:00GlobeNewswire Inc.Belite Bio to Participate in the BTIG Ophthalmology DayNASDAQ:BLTEBelite Bio Inc
13/11/202319:15GlobeNewswire Inc.Belite Bio Reports Third Quarter 2023 Operational Highlights and Financial ResultsNASDAQ:BLTEBelite Bio Inc
10/11/202307:35GlobeNewswire Inc.Deutsche Bank ADR Investor Conference: Presentations Now Available for Online ViewingNASDAQ:BLTEBelite Bio Inc
07/11/202307:00GlobeNewswire Inc.Belite Bio to Host Webcast on November 14, 2023, to Discuss Third Quarter 2023 Financial ResultsNASDAQ:BLTEBelite Bio Inc
06/11/202315:00GlobeNewswire Inc.Belite Bio, Inc. to present at the Deutsche Bank ADR Virtual Investor Conference on 8 November 2023NASDAQ:BLTEBelite Bio Inc
06/11/202307:00GlobeNewswire Inc.Belite Bio Presents Results from a 24-month, Phase 2 Study of Tinlarebant in Childhood-onset Stargardt Disease at the AAO Annual MeetingNASDAQ:BLTEBelite Bio Inc
01/11/202307:35GlobeNewswire Inc.International companies to host live webcasts at Deutsche Bank’s Depositary ReceiptsNASDAQ:BLTEBelite Bio Inc
27/10/202307:00GlobeNewswire Inc.Belite Bio Announces Presentation at the American Academy of Ophthalmology 2023 Annual MeetingNASDAQ:BLTEBelite Bio Inc
19/09/202311:08Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:BLTEBelite Bio Inc
16/06/202315:38Edgar (US Regulatory)Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)NASDAQ:BLTEBelite Bio Inc
01/06/202315:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:BLTEBelite Bio Inc
31/05/202305:03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:BLTEBelite Bio Inc
 Showing the most relevant articles for your search:NASDAQ:BLTE

Su Consulta Reciente

BIT
CBND
Gs Access China Governme...
AMEX
PEX.U
BIT
F16743
Vontobel Financial Produ...
COIN
ETMCGBP
COIN
TVCUST
AMEX
CGDV
Capital Group Dividend V...
NASDAQ
BPYPP
Brookfield Property Part...
UNSW
XRAETH
MasterXriba
BIT
UC277A
Unicredit Bank
AQSE
IQG.GB
IQGeo
EU
Q898S
Q898S
LSE
17OV
Utd Utl Wt F 25
LSE
IN90
Euro.bk 27
COIN
NCPBTC
LSE
AEP
Anglo-eastern Plantations
COIN
ASHHETH
Burn
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados